Pedro J. Beltran
About Pedro J. Beltran
Pedro J. Beltran serves as the Chief Scientific Officer at Bridge Bio Oncology Therapeutics, bringing over 25 years of experience in oncology research and drug development, with a strong focus on cancer genetics and immunotherapy.
Current Role at BridgeBio Oncology Therapeutics
Pedro J. Beltran serves as the Chief Scientific Officer (CSO) at BridgeBio Oncology Therapeutics, a position he has held since 2023. In this role, he focuses on advancing oncology research and drug development initiatives. His responsibilities include overseeing scientific strategy and ensuring the effective execution of research programs aimed at addressing unmet medical needs in cancer treatment.
Previous Experience at Amgen
Pedro J. Beltran has extensive experience at Amgen, where he held multiple positions from 2003 to 2017. He began as a Senior Scientist and Research Scientist, later advancing to Principal Scientist in Oncology Research. He served as Director of Oncology Research & Research Imaging Sciences and as Executive Director of Immuno-Oncology Research. His tenure at Amgen contributed to significant advancements in cancer therapeutics and research methodologies.
Academic Background and Education
Pedro J. Beltran earned his Bachelor of Science degree in Molecular Biology from the Florida Institute of Technology, where he studied under A. Leonard Lab from 1988 to 1992. He then pursued a Ph.D. in Cancer Biology at The University of Texas Health Science Center at Houston, working in I. J. Fidler Lab from 1992 to 1998. He completed a Postdoctoral Fellowship in Molecular and Cellular Pharmacology at the University of Miami from 1998 to 2001.
Expertise in Oncology Research
Pedro J. Beltran possesses over 25 years of experience in oncology research and drug development. His expertise includes cancer genetics, cancer immunotherapy, biomarker development strategies, and phase I pharmacodynamic assay design. He has a strong background in molecular pharmacology and technology innovation, with specific knowledge in IGF1R/PI3K and MAPK signaling pathways, as well as the FGFR and BCL2 families.
Leadership Roles in Biotechnology
In addition to his role at BridgeBio, Pedro J. Beltran served as Senior Vice President and Head of Biology at UNITY Biotechnology from 2017 to 2020. His leadership experience spans both large and small organizational settings, demonstrating his ability to manage diverse teams and drive research initiatives effectively.